Federal contract award

75A50123F61005

PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BUL

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75A50122D00002
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$4.7M
Current contract value$4.7M
Potential contract value / ceiling$4.7M
Start dateDec 12, 2022
Current end dateFeb 21, 2024
Potential end dateFeb 21, 2024
Latest award activityJul 31, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 31, 2026P00002$-0THE PURPOSE OF THIS NO-COST MODIFICATION IS TO: TO CORRECT THE PERIOD OF PERFORMANCE DATE FOR CLIN(S) 3000 & 6000 FROM 2/22/2022-2/21/2025 TO 2/22/2022-2/21/2024. THIS MOD WILL ALSO UPDATE THE CONTRACTING OFFICER FROM DEITRA WILLIAMS TO RY
Jan 10, 2025P00001$0THE PURPOSE OF THIS NO-COST MODIFICATION IS TO: TO CORRECT THE PERIOD OF PERFORMANCE DATE FOR CLIN(S) 3000 & 6000 FROM 2/22/2022-2/21/2025 TO 2/22/2022-2/21/2024. THIS MOD WILL ALSO UPDATE THE CONTRACTING OFFICER FROM DEITRA WILLIAMS TO RY
Dec 12, 20220$4.7MPURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BUL

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.